US 11028079
Small molecule BET bromodomain inhibitors and uses thereof
granted A61PA61P25/28A61P31/18
Quick answer
US patent 11028079 (Small molecule BET bromodomain inhibitors and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P25/28, A61P31/18, A61P35/00, A61P35/02